Aurinia Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 7 analysts polled by S&P Global, Aurinia Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $17. The average 1-year stock price forecast is 7.32% higher than the current stock price, while the lowest is $15 (-5.30%) and the highest is $21 (+32.58%).

Price Target: $17 (+7.32%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$15	$17	$17	$21
Change	-5.30%	+7.32%	+7.32%	+32.58%

Analyst Ratings

The average analyst rating for Aurinia Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	4	4	4	4	4
Buy	0	0	0	0	0	0
Hold	3	3	3	3	3	3
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Martin PhD Bloom Burton	Bloom Burton	Hold Maintains $15	Hold	Maintains	$15	-5.30%	May 11, 2026
Douglas Miehm RBC Capital	RBC Capital	Hold Reiterates $15	Hold	Reiterates	$15	-5.30%	May 8, 2026
Stacy Ku TD Cowen	TD Cowen	Buy Maintains $17	Buy	Maintains	$17	+7.32%	May 7, 2026
Arthur He CFA H.C. Wainwright	H.C. Wainwright	Buy Reiterates $17	Buy	Reiterates	$17	+7.32%	Feb 27, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

324.39M

from 283.06M

14.60%

from 283.06M

Revenue Next Year

386.92M

from 324.39M

19.28%

from 324.39M

EPS This Year

0.96

from 2.07

-53.62%

from 2.07

EPS Next Year

1.12

from 0.96

16.46%

from 0.96

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	45.61M	134.03M	175.51M	235.13M	283.06M	324.39M
Revenue Growth	-9.01%	193.89%	30.95%	33.97%	20.38%	14.60%
Gross Profit	-6.63M	83.38M	111.72M	186.10M	217.89M	295.19M
Gross Margin	-14.53%	62.21%	63.66%	79.15%	76.98%	91.00%
Operating Income	-180.74M	-111.47M	-85.79M	12.52M	116.26M	157.87M
Net Income	-180.97M	-108.18M	-78.02M	5.75M	287.20M	132.38M
EPS	-	-	-	-	2.07	0.96
EPS Growth	-	-	-	-	5,075.00%	-53.62%
Forward PE	-	-	-	24.06	19.69	16.50
Free Cash Flow	-98.48M	-35.10M	-3.89M	62.94M	91.41M	128.00M
No. Analysts	-	-	-	-	-	7

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	343.0M
Avg	324.4M
Low	310.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	21.2%
Avg	14.6%
Low	9.5%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	0.96
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-53.6%
Low	-